CARMEL, Ind. (AP) _ Assembly Biosciences Inc. (ASMB) on Thursday reported a loss of $21.5 million in its third quarter.
On a per-share basis, the Carmel, Indiana-based company said it had a loss of 87 cents.
The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $1.02 per share.
The biotech drug developer posted revenue of $4.3 million in the period, also exceeding Street forecasts. Three analysts surveyed by Zacks expected $3.2 million.
Assembly Biosciences shares have decreased 50 percent since the beginning of the year. The stock has fallen 30 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ASMB at https://www.zacks.com/ap/ASMB